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Objective: To elaborate a brief but efﬁcient neuropsychological assessment of frontotemporal dementia
(FTD), selecting the most speciﬁc and sensitive cognitive and behavioural items for distinguish between
AD and FTD in the earlier dementia stages.
Methods: Retrospective studywith three groups, 35 patientswith FTD, 46with AD and 36 normal subjects,
were administered the MMSE, FAB, Tower of London and Stoop’s test along with a 98 items behavioural
and cognitive questionnaire. Themost sensitive itemswere selected and validated internally for diagnosis
by lineal discriminant analysis.
Results: From the 98 items in the questionnaire, 29 showed signiﬁcant discriminatory power. Non-
cognitive symptoms with higher odd-ratio for FTD compared to AD were impairment in social behaviour
(disinhibition, aggressiveness), loss of insight and inappropriate acts. Language disorders, such as
echolalia, verbal apraxia or aggramatism, dominate in the cognitive proﬁle of FTD. FAB was conﬁrmed
as the best cognitive instrument to differentiate FTD and AD. A linear discriminant function with the
combination of the FAB score and the items from our questionnaire with higher OR for FTD accurately
classiﬁed 97% of individuals.
Conclusions: The neuropsychological tests allow the differentiation between FTD and AD. The combina-
tion of FAB test with the assessment of key behavioural and cognitive symptoms appears helpful in this
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. Introduction
Frontotemporal dementia (FTD) accounts for 3–10% of dementia
n post-mortem investigations [1–4], while clinical series on pre-
enile dementia have reported a frequency of FTD up to 20% [5,6].
lthough FTD has become increasingly recognized by clinicians,
n earlier stages its clinical diagnosis is sometimes blurred with
lzheimer’s disease (AD). Moreover, despite striking neuropsycho-
ogical differences between AD and FTD, NINCDS–ADRDA criteria
ften fail to distinguish between these diseases, since many FTD
atients fulﬁll criteria for AD [7]. Heterogeneity of the clinical forms
f FTD and the lack of a classiﬁcation of FTD until recent years add
ncertainty to this differentiation.Lund and Manchester criteria for FTD diagnosis [4], with the
ater modiﬁcation by Neary et al. [5], are currently unanimously
ccepted as the “gold standard” for the clinical diagnosis of these
atients. Nevertheless, difﬁculties in ascertaining some cases with
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TD are common [8–10]. Therefore, additional clinical or neurobio-
ogical markers are still needed in this regard. Neuropsychological
ssessment has been used in several studies to differentiate these
iseases by looking into either cognitive or behavioural traits of
ach disease [3,11–16]. However, the importance of considering
oth types of symptoms jointly has been only recently stressed
17,18]. Considering the aforementioned issues we conducted a ret-
ospective study using a clinical assessment that included both
ognitive and behavioural testing, intended to select the most spe-
iﬁc and sensitive items in order to get an efﬁcient and direct
iscrimination of FTD patients from AD.
. Patients and methods
We carried out a retrospective chart review and database search
f the patients diagnosed with FTD in an outpatient Neurology
epartment of a Community Hospital during a 3-year period. The
tudy included 35 subjects in the FTD group, which had a pre-
ious clinical diagnosis based on Neary et al. criteria [4,5], and
6 subjects in the AD group that met a diagnosis of probable
D by NINCDS-ADRDA criteria [19]. The control group comprised
6 subjects cognitively normal and without previous history of
2 gy and Neurosurgery 111 (2009) 251–255
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Table 1
Mean age, age at onset and MMSE score for all the groups.
Item FTD AD Control
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ables of the behavioural and cognitive questionnaire, which better
correlated with the FAB items were loss of insight (Spearman’s
r=−0.444; p=0.01) and inappropriateness (Spearman’s r=−0.338;
p=0.01).
Table 2
Behavioural and cognitive questionnaire. Odds-ratio FTD vs. AD. NC: odd ratios not
calculable because one of the groups (Alzheimer) is 0. Numbers in italics are the
numbers of the questions on Appendix A.
Item Odds ratio 95% CI
Inappropiateness (1) 8.182 1.660–40.317
Aggresiveness (2) 14.826 1.785–123.151
Loss of social awareness (3) 3.375 1.186–9.605
Poor organization (6) 2.579 0.835–7.969
Mental rigidity (7) 5.400 1.067–27.328
Perseveration (8) 3.818 1.081–13.486
Inappropiateness (9) 5.273 1.325–20.984
Loss of insight (10) 9.900 3.025–32.395
Dietary changes (11) 9.538 1.119–81.335
Memory impairment (12) 0.257 0.049–1.346
Disorientatión (14) 0.938 0.124–7.083
Confusion episodes (15, 16) 5.984 1.513–23.675
Economy of utterance 1.095 0.393–3.049
Agrammatism (17) 6.840 2.123–22.038
Anomia (18) 5.769 1.946–17.103
Fluent aphasia (19) 6.075 1.889–19.534
Disprosody (20) NC NC
Sluttering (21) 13.333 2.741–64.85552 A.H. Valverde et al. / Clinical Neurolo
eurological or psychiatric illness. Age and sex distributions were
imilar in the three groups. Neuropsychological tests were done
y staff that were independent from those that participated in the
linical diagnosis. Additional information was obtained through an
nterview of the patient and its main caregiver, as well as supple-
ented by behavioural observation. Randomautopsy conﬁrmation
as possible in about 10% of cases with exact clinicopathological
orrespondence.
Dementia was staged according to the Clinical Dementia Rating
CDR) [20]. Cognitive assessment included MMSE in its version val-
dated for the Spanish population [21] and speciﬁc frontal tests as
rontal Assessment Battery (FAB) [11], Stroop’s [22] and Tower of
ondon [23] tests. In order to use a homogeneous set of cases for
omparison, only patients with an MMSE score higher than 12 and
DR 1–2 were included in the study.
FAB [11] and its six different items, conceptualization, mental
exibility,motor programming, resistance to interference, inhibitor
ontrol, and environmental autonomy [24–26] were assessed. Each
temwas scored from0 to3 (0=none; 3 =maximumcorrect) [11,14].
troop’s test [22] was scored considering the number of failures
nd the time required to complete the test. The test was inter-
upted if the patient reached an upper limit of 20 failures or 120
econds to moderate the ceiling effect. The Tower of London test
23] was undertaken using a computer version in MS-DOS TBasic,
eveloped speciﬁcally for this study. This software program allows
he examiner to select the model to be tested (from 1 to 5 min-
mal movements) and scores the initial latency or time until the
atient made the ﬁrst movement, number of movements and total
ime employed in the task. The evaluator keys into the program the
atient commands. The test was interrupted if the patient reached
nupper limit set at twice theminimalmovementsplus one, or plus
wo when the minimal movements were ﬁve. There was no time
imit. Patients who could not ﬁnish the test or who made more
ovements than the maximum allowed were computed as unable
o complete the test. As this study was retrospective, Stroop’s and
ower of London test could only be assessed in a sub-set of patients.
In addition, we developed a 98-item questionnaire with
ehavioural and cognitive sections. It was based on the Frontal
ehavioural Inventory (FBI) [27], Lund and Manchester items [4]
nd the Spanish version of the CAMDEX interview for the care-
iver [28]. If the caregiver did not understand the question as it
as constructed, a different question related to the same targetwas
sked. The language testing was based not only on the caregiver’s
eport, but alsoondataobtainedduring thepatient evaluation. Each
tem was scored on a 0–3 scale, with 0 designating absence of the
ymptom and 3 its maximum severity (see Appendix A).
Statistical data was analyzed with the software SPSS 10.0. Non-
umerical data (sex, items from the behavioural and cognitive
uestionnaire) was examined using the Chi-square (2) test. For
umerical data (age distribution,MMSE score, FAB score and Tower
f London test results) the Kruskal–Wallis test, a non-parametric
lternative to ANOVA test, was used. Dichotomy comparisons (e.g.,
ge at onset) were done with the Student’s t-test. The behavioural
nd cognitive questionnaire data was grouped in normal (score
–1) and abnormal (2–3) for odd-ratio calculations. Cut-off points
f FAB, Tower of London and Stroop’s tests were determined by
eceiver Operator Characteristics (ROC) curves and calculating the
rea under the receiver operator curve (AUC). Correlation between
tems in the behavioural and cognitive questionnaire and the dif-
erent items of the FAB test was examined with the Spearman
orrelation coefﬁcient.
Finally, for internal validation of the results we calculated the
ower to classify patients into two groups according to a linear
iscrimination function. Two models were calculated using the
iagnosis of FTD or AD as the non-numerical variable. The ﬁrst
P
A
P
L
Eean age 67 ± 9.23 73.48 ± 5.64 64.72 ± 11.02
ge at onset 63.57 ± 9.58 70.33 ± 5.54
MSE 18.71 ± 9.39 22.35 ± 5.69 32.69 ± 2.56
ne used only the FAB score as a predictor variable, and the sec-
nd one included the FAB score and those items of the behavioural
uestionnaire which were statistical signiﬁcant.
The study was approved by the Research Ethics Committee of
he Ramon y Cajal Hospital. Informed consent was obtained from a
urrogate decision maker.
. Results
.1. Sociodemographic variables
Forty-nine men and sixty-eight women were enrolled, without
tatistical differences in gender between the three groups (2(2)
.305; p>0.05). The age at onset was lower in the FTD group
ompared to the AD group (Student’s t; p=0.000). There were
o statistical differences in the CDR score (FTD: 1.23±0.77; AD:
.24±1.35) (Student’s t; p=0.965) or the MMSE between the FTD
nd AD groups (Student’s t; p=0.061) (Table 1).
.2. Non-cognitive symptoms
The more frequent non-cognitive symptoms in the FTD group
ere mental rigidity (84%), apathy (79%), loss of insight (76%), dis-
rganization (76%) and aspontaneity (73%).
The symptoms with highest sensitivity for FTD (highest OR)
ere loss of social awareness (disinhibition, aggressiveness), loss of
nsight, inappropriateness and mental rigidity (Table 2). The vari-erseveration (22) NC NC
grammatism (23) 11.160 1.323–94.111
araphasias (24, 25, 26) NC NC
oss of word meaning (27, 28) 1.261 0.476–3.338
cholalia (29) 19.190 2.331–157.983
A.H. Valverde et al. / Clinical Neurology and
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.3. Cognitive symptoms
Language disorders dominated in the cognitive proﬁle of
TD. They included anomia, semantic aphasia, echolalia, palilalia,
ysprosody, ﬂuent aphasia, phonemic or semantic paraphasias,
ggramatism and stuttering. On the other hand, memory impair-
ent, spatial disorientation or confusional spells were very rare in
he FTD group (Table 2). Patients with FTD showed a signiﬁcantly
ower score onevery itemandon the total score of FAB, compared to
D and normal controls (Kruskal–Wallis; p=0.01) (Fig. 1). Themost
ensitive FAB item for the diagnosis of FTD was resistance to inter-
erence (97%) followed by mental ﬂexibility and inhibitor control
94% each). The ﬁrst one was also the most speciﬁc (100%). Envi-
onmental autonomy reached this speciﬁcity as well. According to
OC curves, resistance to interference was the most valuable item
or FTD diagnosis with an AUC±CI of 0.985±0.15.
The Tower of London test was applied to 13 patients with FTD
but only three were able to complete it), 39 patients with AD, and
1 healthy controls. This test showed a low capability to discrimi-
ate between FTD and AD but was useful to distinguish dementia
ases from controls. Although this test did not allow discrimina-
ion between the two groups, according to the ROC results the
ost useful items for the evaluation of patients with FTD were the
umber of movements in the two movement paradigm (AUC±CI
5%=0.799±0.081) and the total time of execution in the ﬁve
ovement paradigm (AUC±CI 95%=0.806±0.082).
Stroop’s test was performed by 29 cases with FTD, 40 with AD,
nd 36 normal controls. As with the Tower of London test, Stroop’s
est was accurate for the diagnosis of dementia, but could not dif-
erentiate FTD from AD. Nevertheless, execution time for all the
tems (reading, colour identiﬁcation, attention and sensitivity to
nterference) had a higher discrimination power than number of
istakes.
n
e
s
A
a
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.4. Discriminant analysis
With a linear discriminant function, the FAB score classiﬁed cor-
ectly only 79% of the patients, while the combination of the FAB
core and the items from our questionnaire with higher OR for
TD accurately classiﬁed 97%of individuals (sensitivity 100%, speci-
city 93%, negative predictive value 100%, positive predictive value
4%). Only two cases, AD patients that were allocated in the FTD
roup, were incorrectly classiﬁed using this function. The graphi-
al representation of the discriminant function named “L” (Fig. 2)
as utilized to deﬁne a decision rule, so that for L>0.5 the pro-
osed diagnosis was FTD and for L<−0.1 the proposed diagnosis
as AD.
. Discussion
We recommend the use of a neuropsychological evaluation to
iscriminate FTD from AD, as previous studies have done [18,29].
mong the 98 questions taken from previously reported invento-
ies, we selected 29 based on their higher OR for FTD or better
orrelation with FAB items. These 29 selected questions are listed
n Appendix A. The validity of this reduction was proven internally
ith the discriminant analysis.
Similar scales have been reported to diagnose FTD and differ-
ntiate it from AD with high diagnostic accuracy [11,27,30]. The
BI [27], speciﬁcally designed to quantify the behavioural disor-
er of FTD, is particularly useful in early stages. Its discriminating
ower decreases as disease progresses, due to the disappearance
f some symptoms and the appearance of others [30]. The Mid-
elheim Frontal Score [30] is also a helpful assessment tool that
etectsmainlybehavioural symptoms.Although theseappearmore
ensitive than cognitive testing in FTD [31], it also includes cog-
itive items [18]. The FAB [11] accurately discriminates between
atients with frontal lobe dysfunction from normal controls, but
he sensitivity and speciﬁcity to differentiate FTD from AD are not
ery high (77% and 87%, respectively) in mildly demented groups
14,32].
Our scale endeavoured to join the more reliable behavioural
tems of previous scales with speciﬁc cognitive characteristics to
mprove the differential diagnosis of FTD and AD. The assessment
as performed in a clinical series. This may be considered a ﬂaw,
ince several items of the scale were taken from the clinical diag-
ostic criteria of FTD [4,5], potentially indicating a risk of a circular
valuation. In this regard, randomcases of this serieswith necropsy
tudy showed concordance with the established clinical diagnosis.
dditionally, formerly published studies showed high diagnostic
ccuracy in clinically diagnosed patients [30]. Power calculations
f the discriminant function.
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ere not considered necessary for a retrospective study, but lack
f differences in some items could be due to underpower for some
utcomes.
Solely cognitive tests undertaken in isolation are valid for the
xamination of executive function and attention deﬁcits. How-
ver, they are unable to discriminate AD from FTD [32]. Despite
he different pattern of brain damage, both groups showed a poor
erformance on Stroop’s and Tower of London tests, secondary
o an inhibitory dysfunction related to the disconnection within
he network of cerebral areas recruited during the performance
f these tests [33,34]. In our series, only speciﬁc criteria sub-
ets of the FAB test were useful, such as the mental ﬂexibility,
hich indicated a good sensitivity and the environmental auton-
my which had high speciﬁcity, conﬁrming established reports
35].
The most prevalent behavioural and cognitive symptoms for
he FTD group were apathy, loss of insight, perseveration, personal
eglect, logopenia, anomia and semantic aphasia as described pre-
iously [3]. Among these, loss of insight and anomia were the most
ensitive, along with inappropriateness and aggramatism.
We point to the importance of assessing language performance,
s this function is affected in all FTD phenotypes [36]. Moreover,
he typical aphasic proﬁle of FTD is different from AD, so it may
ave additional usefulness to distinguish between these two types
f dementia [36].
In conclusion, our study supports that the neuropsychological
tudy of FTD must include a behavioural questionnaire together
ith frontal lobe function tests. Selected questions from thebattery
sed for thediagnosis of FTDalongwith the FAB test canbeusewith
good clinical reliability in distinguishing FTD from AD.
ppendix A
.1. FTD questionnaire (applied to the caregiver)
Inform the caregiver that we are looking for changes in previ-
us status. Score will be done according to the following: 0 =none;
=mild, occasional; 2 =moderate; 3 = severe, most of the time.
1. Has s/he kept social rules or has s/he said or done things that
are unacceptable?
2. Has s/he shown physical or verbal aggression?
3. Does his/her behaviour have serious social consequences (e.g.,
separation, lose of job, imprisonment, etc.)?
4. Does s/he deny any problems when discussed?
5. Is s/he aware if s/he does anything wrong (e.g., inappropriate
conduct such as behaving rudely or childishly)?
6. Is s/he able to ﬁnish the activities that s/he initiates?
7. Does s/he have recurrent ideas that s/he cannot avoid?
8. Does s/he do acts without sense, unnecessarily or ritualisti-
cally?
9. Does s/he look into the rubbish or likes keeping unnecessary
things?
10. Is s/he worried because of any repetitive acts or ideas?
11. Has s/he changed her/his diet?
12. Does s/he have difﬁculty in remembering a small list of things?
13. Does s/he have difﬁculty in remembering recent events?
14. Does s/he have any difﬁculty in ﬁnding her/his way home?
15. Does s/he have spells of confusion?
16. Is her/his level of impairment ﬂuctuant during a given day (or
during the course of the day)?
17. Has her/his conversational ﬂuency decreased?
18. Does s/he have any difﬁculty in naming objects?
[
[
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19. Does s/he use ﬂuent, effortless language but without meaning?
0. Is her/his voice monotonous and constant?
21. Is there stuttering or hesitation in her/his speech?
2. Does s/he repeat phonemes quickly, effortlessly?
3. Does s/he construct sentences correctly?
4. Does s/he reverses words?
5. Does s/he make mistakes during conversations (phonemes
changes)?
6. Does s/he use correct words but with a personal and wrong
meaning?
27. Has s/he had more difﬁculty in understanding words than in
the past?
8. Has s/he had any difﬁculty in understanding orders or a simple
conversation?
9. Does s/he repeat the last words said by another person?
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